10x Genomics is seeking additional injunctions to protect its intellectual property
PLEASANTON, Calif., May 17, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq:TXG), a leader in single cell and spatial biology, today announced that it has won an injunction in its patent litigation against NanoString Technologies, Inc. (Nasdaq:NSTG) and NanoString Technologies Germany GmbH.
Read more at prnewswire.com